Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis
Findings from both population-based and genetic analyses suggest a possible protective association between aspirin use and HCC in patients with MASLD, which warrants further validation.
Authors
- Min Kyung Park (ORCID: https://orcid.org/0000-0002-6065-3367)
- Hyun‐Jae Shin (ORCID: https://orcid.org/0000-0003-1023-8795)
- Moon Haeng Hur (ORCID: https://orcid.org/0000-0001-5463-6782)
- Youngsu Park (ORCID: https://orcid.org/0009-0002-8987-6174)
- Eun Ju Cho (ORCID: https://orcid.org/0000-0002-2677-3189)
- Jung‐Hwan Yoon (ORCID: https://orcid.org/0000-0002-9128-3610)
- Yun Bin Lee (ORCID: https://orcid.org/0000-0002-3193-9745)
- Su Jong Yu (ORCID: https://orcid.org/0000-0001-8888-7977)
- Jeong-Hoon Lee
- Jeayeon Park (ORCID: https://orcid.org/0000-0003-1155-0588)
- Sungho Won (ORCID: https://orcid.org/0000-0001-5751-5089)
- Yoon Jun Kim (ORCID: https://orcid.org/0000-0001-9141-7773)
- Juhee Ahn
- Y C Ko (ORCID: https://orcid.org/0009-0004-8751-0309)
Institutions
- Seoul National University (KR)
- University of Suwon (KR)
- New Generation University College (ET)
- Seoul National University Bundang Hospital (KR)
- Advanced Institute of Convergence Technology (KR)
- Suwon Science College (KR)
Publication Details
- Journal
- Clinical and Molecular Hepatology
- Published
- 2025-11-25
- DOI
- https://doi.org/10.3350/cmh.2025.0528
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Yuhan
- Korean Association for the Study of the Liver
- Korean Liver Foundation